Evidence map›Paper›PMID 38695556›Full record

ArticleMicrobiology spectrum2024

Spectrum of activity and mechanisms of azole-bisphosphonate synergy in pathogenic

Aidan Kane, Hue Dinh, Leona Campbell, Amy K Cain, David Hibbs, Dee Carter

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Combining Fluconazole with Benzo[Molecules (Basel, Switzerland) · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Aidan KaneSchool of Life and Environmental Sciences and the Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-4927-0071
Hue DinhSchool of Natural Sciences, ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, New South Wales, Australia.
Leona CampbellSchool of Life and Environmental Sciences and the Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, New South Wales, Australia.
Amy K CainSchool of Natural Sciences, ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, New South Wales, Australia.
David HibbsSchool of Pharmacy, The University of Sydney, Sydney, New South Wales, Australia.
Dee CarterSchool of Life and Environmental Sciences and the Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-4638-0059
The University of Sydney · AUARC Centre of Excellence in Synthetic Biology · AU

Funding

USYD | Marie Bashir Institute, University of Sydney (Marie Bashir Institute)
6 · The paper itself

Abstract

Candidiasis places a significant burden on human health and can range from common superficial vulvovaginal and oral infections to invasive diseases with high mortality. The most common IMPORTANCE:

Indexed as

Antifungal AgentsAzolesCandidaDiphosphonatesDrug Resistance, FungalDrug SynergismMicrobial Sensitivity TestsAnimalsBiofilmsCandida albicansCandida glabrataCandidiasisFluconazoleHumansAntifungal AgentsAzolesDiphosphonatesFluconazoleazolebisphosphonateCandida albicansCandida glabratadrug synergyfluconazolemevalonate pathwayzoledronate

Identifiers

PMID38695556
PMCPMC11237636
OpenAlexW4396580411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.